Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04697160 · ClinicalTrials.gov registry record
Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL
A clinical trial, sponsored by MorphoSys.
- Completed
- Registry status
- 3,573
- Enrollment target
NCT04697160: Completed study, sponsored by MorphoSys.
NCT04697160 is a clinical trial that has completed, run by MorphoSys. The registered enrollment target is 3,573 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04697160 has completed, sponsored by MorphoSys.
- COMPLETED
- Registry status
- 3,573 participants
- Enrollment target
Study Summary
To compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered in routine clinical care.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,573 participants |
| Start Date | 2020-04-01 |
| Est. Completion | 2021-05-07 |
What the finished NCT04697160 record still lists
NCT04697160 is an observational study that tracks outcomes without assigning an intervention. Its 3,573 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT04697160 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04697160 about?
NCT04697160 is a clinical study titled "Observational Retrospective Cohort Study of Systemic Therapies for R/R DLBCL". To compare the efficacy outcomes of the L-MIND cohort with the effectiveness in a matched patient population treated with systemic NCCN/ESMO guideline listed regimens administered in routine clinical care.
What is the current status of trial NCT04697160?
This trial is currently completed. The enrollment target is 3,573 participants. The study started on 2020-04-01. Estimated completion is 2021-05-07.
Who is sponsoring clinical trial NCT04697160?
This trial is sponsored by MorphoSys, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06429787 · 3,574 participants
Post Marketing Observational Study on Safety of BALFAXAR vs. KCENTRA for Reversal of Vitamin K Antagonist Induced Anticoagulation in Adults Undergoing Urgent Surgery or Invasive Procedure
- NCT03199651 · 3,584 participants · NA
Beating Lung Cancer in Ohio Protocol in Improving Survival in Patients With Stage IV Non-Small Cell Lung Cancer
- NCT06088498 · 3,600 participants · Phase 2
App for Reducing Cravings to Smoke
- NCT06501118 · 3,600 participants · NA
Optimizing Care in Critically Ill at UCHealth by Liberalizing the Target O2 in Mechanically-ventilated ICU Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI